Siirry päänavigointiin
Siirry hakuun
Siirry pääsisältöön
Järjestys:
Medicine and Dentistry
Breast Cancer
100%
Cell Proliferation
66%
Neoplasm
54%
Breast Carcinoma
44%
Aneuploidy
34%
Anastrozole
33%
Postmenopause
33%
Diethylstilbestrol
33%
Case-Control Study
33%
Prostate Carcinoma
33%
Flow Cytometry
33%
Visceral Metastasis
33%
Lung Carcinoma
33%
S Phase
33%
Long Term Survival
33%
Cathepsin D
33%
Defibrotide
27%
Placebo
20%
Carcinoma
19%
Prostate Cancer Survival
16%
Tumor Cell
16%
Cell Nucleus
16%
Prostate Cancer
16%
Multivariate Analysis
15%
Prognostic Factor
15%
Lung
11%
Progesterone
11%
Mortality Rate
11%
Metastatic Carcinoma
11%
Adjuvant Therapy
11%
Receptor
11%
Proteinase
11%
Adenocarcinoma
9%
Lung Cancer
9%
Ploidy
9%
Small-Cell Carcinoma
9%
Sex Hormone Binding Globulin
7%
Cancer Research
5%
Cancer Therapy
5%
Aromatase Inhibitor
5%
Treatment Group
5%
Keyphrases
Serum Concentration
33%
Anastrozole
33%
Disease-specific Survival
33%
Breast Cancer
33%
Rising Incidence
33%
Thyroid Patients
33%
Papillary Thyroid Cancer
33%
High-risk Women
33%
Postmenopausal Women
33%
IBIS®
33%
Prevention Trials
33%
Estradiol
33%
Clinical Trials
33%
Thyroid Cancer
33%
Cell Proliferation Activity
33%
Protien
33%
DNA Aneuploidy
23%
Epidermoid Carcinoma
19%
Nucleus Model
16%
Nuclear Debris
16%
Background Subtraction Algorithm
16%
Background Subtraction Method
16%
Overcompensation
16%
DNA Index
16%
DNA Flow Cytometry
16%
Placebo Groups
15%
Tampere
13%
Tumor Size
13%
Cancer Cases
13%
University Hospital
13%
Written Information
11%
Communicative Needs
11%
Decision to Participate
11%
Psychological Support
11%
Treatment Allocation
11%
Adjuvant Therapy
11%
Treatment Methods
11%
Older Patients
11%
Patients with Breast Cancer
11%
DNA Ploidy
9%
Sex Hormone-binding Globulin
9%
Breast Cancer Risk
9%
Placebo
9%
Histogram Classification
8%
Medical Records
6%
Cancer Registry
6%
Papillary Cancer
6%
Follicular Thyroid Carcinoma
6%
Diagnostic Interventions
6%
Cause-specific Survival
6%
Biochemistry, Genetics and Molecular Biology
Cell Proliferation
100%
S Phase
84%
Flow Cytometry
66%
Ploidy
42%
Aneuploidy
40%
Long Term Survival
33%
P53
33%
Cell Count
33%
Cell-Cycle Analysis
33%
Tumor Suppressor Protein
33%
Cancer Survival
33%
Cathepsin D
33%
Multivariate Analysis
24%
Tumor Volume
22%
Cancer Screening
16%
Morphology
16%
Protease
16%
Progesterone
16%
Mortality Rate
16%
